Leonardo DRS
Leonardo DRS's revenue rose 12.8% to $3.6 billion in fiscal 2025. Its operating margin was 9.5%, up from 9.1% a year earlier. Free cash flow was $227 million, up 22.0%. It paid out $35 million in dividends and buybacks, 15% of free cash flow. The diluted share count rose 0.4%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2019 to 2025, earnings per share grew 19.7% a year and net income 24.4% a year.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Leonardo DRS yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Leonardo DRS's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Leonardo DRS's fiscal 2025 free cash flow of $227M, net cash of $188M at December 31, 2025 and 269 million diluted shares, from its filings. The scenarios are fitted to Leonardo DRS: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 10.6% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 10%: 9% for a business of moderate risk (Aerospace & Defense), plus 1 point as a smaller company, worth $9.6B; the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $35.84
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from Leonardo DRS's earnings per share of $1.19 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 30.1×, the middle of Leonardo DRS's own P/E today, its peers' median and its sector's median (Leonardo DRS's own P/E today) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 11%, 10% and 9%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $35.84
- Value at this multiple, against the last close
- —
- Leonardo DRS's P/E at the last close
- 30.1×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| ATIATI | $164.54 | $3.41 | 48.3× |
| BWX TechnologiesBWXT | $131.20 | $3.86 | 34.0× |
| Curtiss-WrightCW | $476.54 | $14.52 | 32.8× |
| MoogMOG-A | $358.27 | $11.76 | 30.5× |
| Leonardo DRSDRS | $35.84 | $1.19 | 30.1× |
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 240 | 306 | 467 | 598 | 647 |
| Debt incl. finance leases | 521 | 519 | 553 | 483 | 459 |
| Net debt (negative means net cash) | 281 | 213 | 86 | −115 | −188 |
| Net debt to EBITDA | 1.0x | 0.3x | 0.3x | −0.3x | −0.4x |
| Debt to equity | 0.3x | 0.2x | 0.2x | 0.2x | 0.2x |
| Interest coverage | 6.7x | 16.5x | 6.4x | 13.9x | — |
| Current ratio | 1.4x | 1.6x | 1.8x | 1.9x | 1.9x |
| Quick ratio | 1.2x | 1.3x | 1.5x | 1.6x | 1.6x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, 1 insider bought $1.1 million of Leonardo DRS shares on the open market, and 7 insiders sold $9.2 million, $8.0 million of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Mark DorfmanEVP, GC and Secretary | Sold plan | 7,471 | $37.01 | $276,502 | Form 4 |
| Sep 2, 2026 | Michael DippoldEVP and CFO | Sold plan | 20,317 | $37.18 | $755,386 | Form 4 |
| Aug 4, 2026 | Jason RinskyEVP Chief Tax and Treasury | Sold plan | 3,864 | $45.81 | $177,010 | Form 4 |
| Jul 7, 2026 | Jason RinskyEVP Chief Tax and Treasury | Sold plan | 3,865 | $45.37 | $175,355 | Form 4 |
| Jun 18, 2026 | John BaylounyPresident and CEO, Director | Sold plan | 36,471 | $45.67 | $1.7 million | Form 4 |
| Jun 11, 2026 | Sally WallaceEVP, Chief Operating Officer | Sold plan | 1,300 | $50.00 | $65,000 | Form 4 |
| Jun 8, 2026 | Michael DippoldEVP and CFO | Sold plan | 8,318 | $46.48 | $386,621 | Form 4 |
| Jun 4, 2026 | Mark DorfmanEVP, GC and Secretary | Sold plan | 5,536 | $45.75 | $253,272 | Form 4 |
| Jun 3, 2026 | Jason RinskyEVP Chief Tax and Treasury | Sold plan | 3,865 | $46.87 | $181,153 | Form 4 |
| May 27, 2026 | Pamela MorrowSVP and Controller | Sold | 11,545 | $45.13 | $521,026 | Form 4 |
| May 19, 2026 | Reuben Jeffery IIIDirector | Bought | 25,000 | $42.77 | $1.1 million | Form 4 |
| Apr 2, 2026 | Sally WallaceEVP, Chief Operating Officer | Sold plan | 28,960 | $46.35 | $1.3 million | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Pass | Pass |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Pass | Pass |
| Current ratio rose | Pass | Pass | Fail |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Pass | Fail | Pass |
| Revenue rose relative to assets | Fail | Pass | Pass |
| F-score | 6 of 9 | 7 of 9 | 7 of 9 |
| Accruals ratio | −1.0% | −1.4% | −2.0% |
Compare
Put Leonardo DRS side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Leonardo DRS | FY25 | 12.8% | 9.5% | 6.2% | 11.6% | −0.4x | 7 | |
| Curtiss-Wright | FY25 | 12.1% | 18.1% | 15.8% | 15.9% | 0.8x | 8 | Compare |
| Moog | FY25 | 7.0% | 11.7% | 3.3% | 11.7% | 1.8x | 7 | Compare |
| BWX Technologies | FY25 | 18.3% | 12.7% | 9.2% | 13.9% | 3.0x | 7 | Compare |
| ATI | FY25 | 5.2% | 14.0% | 7.3% | 16.7% | 1.6x | 9 | Compare |
7 years of figures
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 2,714 | 2,778 | 2,879 | 2,693 | 2,826 | 3,234 | 3,648 |
| Revenue growth | — | 2.4% | 3.6% | −6.5% | 4.9% | 14.4% | 12.8% |
| Gross profit | 459 | 494 | 547 | 575 | 648 | 736 | 869 |
| Research and development | 31 | 41 | 48 | 58 | 82 | 92 | 129 |
| Operating income | 163 | 181 | 236 | 561 | 231 | 293 | 348 |
| Net income | 75 | 85 | 154 | 405 | 168 | 213 | 278 |
| Diluted EPS (US$) | 0.35 | 0.40 | 0.73 | 1.88 | 0.64 | 0.80 | 1.03 |
| Diluted shares (millions) | — | 210 | 210 | 215 | 264 | 268 | 269 |
| Cash flow | |||||||
| Cash from operations | 157 | 125 | 178 | 33 | 205 | 271 | 366 |
| Capital expenditure | 55 | 56 | 60 | 65 | 60 | 85 | 139 |
| Free cash flow | 102 | 69 | 118 | −32 | 145 | 186 | 227 |
| Dividends paid | 0 | 0 | 0 | 396 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 35 |
| Acquisitions | 4 | 0 | 14 | 19 | 0 | 0 | 0 |
| Stock-based compensation | — | 0 | 0 | 5 | 17 | 22 | 32 |
| Balance sheet at fiscal year end | |||||||
| Cash and short-term investments | 85 | 61 | 240 | 306 | 467 | 598 | 647 |
| Debt incl. finance leases | — | 401 | 521 | 519 | 553 | 483 | 459 |
| Total assets | — | 2,956 | 3,069 | 3,677 | 3,921 | 4,184 | 4,486 |
| Total liabilities | — | 1,529 | 1,476 | 1,550 | 1,596 | 1,627 | 1,756 |
| Shareholders' equity | 1,019 | 1,427 | 1,593 | 2,127 | 2,325 | 2,557 | 2,730 |
| Margins and ratios | |||||||
| Gross margin | 16.9% | 17.8% | 19.0% | 21.4% | 22.9% | 22.8% | 23.8% |
| Operating margin | 6.0% | 6.5% | 8.2% | 20.8% | 8.2% | 9.1% | 9.5% |
| Net margin | 2.8% | 3.1% | 5.3% | 15.0% | 5.9% | 6.6% | 7.6% |
| Free cash flow margin | 3.8% | 2.5% | 4.1% | −1.2% | 5.1% | 5.8% | 6.2% |
| Return on capital | — | — | 10.0% | 20.5% | 8.5% | 9.7% | 11.6% |
| Return on equity | — | — | 10.2% | 21.8% | 7.5% | 8.7% | 10.5% |
| Return on assets | — | — | 5.1% | 12.0% | 4.4% | 5.3% | 6.4% |
| Net debt to EBITDA | — | 1.4x | 1.0x | 0.3x | 0.3x | −0.3x | −0.4x |